ACTIVE_NOT_RECRUITING

Determination of Baseline Levels for Prostate Cancer-Derived Extracellular Vesicles Following Local Treatment of Prostate Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is being done to determine whether levels of prostate cancer derived extracellular vesicles from blood and urine specimens correlate with response to primary local treatment (surgery) in prostate cancer.

Official Title

Determination of Baseline Levels for Prostate Cancer-Derived Extracellular Vesicles Following Local Treatment of Prostate Cancer

Quick Facts

Study Start:2020-06-10
Study Completion:2026-12-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT06326216

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * PROSTATE CANCER PATIENTS:
  2. * Age 18+
  3. * Able to give informed consent
  4. * Patients with prostate cancer
  5. * Patients treated with primary prostatectomy
  6. * The focus will be on high-risk patients with at least one of either criterion:
  7. * PSA \>= 20 ng/ml
  8. * AND/OR Gleason \>= 8
  9. * AND/OR clinical stage \>= T3
  10. * FEMALE CONTROL PATIENTS:
  11. * Age 18+
  12. * Able to give informed consent
  1. * PROSTATE CANCER PATIENTS:
  2. * Unable or unwilling to provide informed consent
  3. * Metastatic prostate cancer - defined evidence of metastatic disease on pre-procedural testing
  4. * FEMALE CONTROL PATIENTS:
  5. * Unable or unwilling to provide informed consent

Contacts and Locations

Principal Investigator

Eugene D. Kwon, M.D.
PRINCIPAL_INVESTIGATOR
Mayo Clinic in Rochester

Study Locations (Sites)

Mayo Clinic in Rochester
Rochester, Minnesota, 55905
United States

Collaborators and Investigators

Sponsor: Mayo Clinic

  • Eugene D. Kwon, M.D., PRINCIPAL_INVESTIGATOR, Mayo Clinic in Rochester

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-06-10
Study Completion Date2026-12-01

Study Record Updates

Study Start Date2020-06-10
Study Completion Date2026-12-01

Terms related to this study

Additional Relevant MeSH Terms

  • Prostate Carcinoma